Xalkori 50 mg, filmüberzogenes Granulat zum Einnehmen
7680694670029
CH-69467
Granulat
Associated product:
XALKORI gran 50 mg gélules à ouvrir bte 60 pce
1 / 3
google
Article details
- Package size
- 60
- Selling units
- 60
- Measure
- Kapsel(n)
- Galenic form
- Granulat
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
crizotinibum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
alcohol stearylicus
|
- | Substance | HNIDK |
|
poloxamerum 407
|
- | Substance | HNIDK |
|
saccharum
|
14.29 MG | Substance | HBESI |
|
talcum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 4000
|
- | Substance | HNIDK |
|
glyceroli mono/dipalmitas/stearas/oleas
|
- | Substance | HNIDK |
|
triglycerida media
|
- | Substance | HNIDK |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69467
- Drug name
- Xalkori, filmüberzogenes Granulat zum Einnehmen
- Galenic form
- GRFI
- ATC Code
- L01ED01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 29/08/2024
- Authorization expiration date
- 28/08/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- XALKORI gran 50 mg gélules à ouvrir bte 60 pce
- Description (DE)
- XALKORI Gran 50 mg Kapseln zum Öffnen Ds 60 Stk
- Market launch
- 29/08/2024
- Narcotic (BTM)
- No